Kuahiwi Management LLC (KCap) provides investment advisory services to private investment funds. KCap aims to achieve capital appreciation through investments in publicly traded common stock and other equity-like financial instruments within the healthcare, primarily the pharmaceutical and biotechnology industries. The firm's objective is to identify undervalued smaller biopharmaceutical companies.
Fee Structure
Kuahiwi Management manages investments for private investment funds and charges a quarterly asset-based management fee, calculated as a percentage of each investor’s capital account. The management fee is generally between 1.25% and 2.0% annually, paid quarterly in advance. The firm also receives a performance allocation equal to a percentage of the net income allocated to each investor, generally between 15% and 20%, typically made at the end of each calendar year.